Results 261 to 270 of about 344,100 (302)

A case report of idiopathic pulmonary fibrosis concurrent with <i>EGFR</i> 19 deletion lung adenocarcinoma. [PDF]

Transl Cancer Res
Li Z, Xu K, Chen R, Shi Y, Wang M, Chen Q, Li J, Shao C, Huang H.   +8 more
europepmc   +1 more source

Effectiveness and safety of cyclosporine A in moderate to severe COVID-19: a randomized, open-label trial. [PDF]

Sci Rep
Zidan AA, Gad AYS, Zakaria NH, El-Hariri HM, Elsharnouby NM, Helmy MW, El-Setouhy M.   +6 more
europepmc   +1 more source

Alcohol- and drug-related mortality in Brazil: an ecological and population-based study on changes observed during the COVID-19 pandemic. [PDF]

Lancet Reg Health Am
Almeida Andrade L, Amélia Dos Santos Lemos Gurgel M, Silva da Paz W, Rocha Monteiro G, Conceição Gomes de Araújo K, Dantas Dos Santos A, Dornels Freire de Souza C, Sousa ÁFL, Cepas LA, Morais Fernandes AP, Dos Santos Tavares D, Rodrigues de Moura T, Bezerra-Santos M.   +12 more
europepmc   +1 more source

Narrative Review of Opioid Use Disorder Treatment Changes During the COVID-19 Pandemic and Their Impact on American Indian/Alaska Native Communities. [PDF]

Nurs Open
Bingham-Hendricks C, Peters-Mosquera A, Aronowitz SV, Woods C, Aronowitz T.   +4 more
europepmc   +1 more source

The role of artificial intelligence in managing COVID-19 and long COVID: a narrative review. [PDF]

Osong Public Health Res Perspect
Sarkar BK, Kumar A.
europepmc   +1 more source

COVID-19 Antiviral Prescription Receipt Among Outpatients Aged ≥65 Years - United States, June 1, 2023-September 30, 2025. [PDF]

MMWR Morb Mortal Wkly Rep
Raykin J, Rochin I, Wiegand R, Soto V, Nyame-Mireku A, Chung A, Mak J, Boehmer T, Patel P.   +8 more
europepmc   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai, Hirohiko Aikawa, Yoshiaki Morita, Keiko Ohta‐Ogo, Teruo Noguchi   +4 more
wiley   +1 more source

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.

JAMA Dermatol
Kimball AB, Sawicki KT, Ackerman L, Lima H, Giamarellos-Bourboulis EJ, Zhan T, Drogaris L, Gu Y, Lee CM, Akbari M, Williams DA, Bechara FG.   +11 more
europepmc   +1 more source